Real-world Experience on the Use of Upadacitinib in the Treatment of Moderate-severe Adult Atopic Dermatitis (ERUDA)
NCT05989932
·
clinicaltrials.gov ↗
COMPLETED
Status
146
Enrollment
OTHER
Sponsor class
Conditions
Atopic Dermatitis
Interventions
OTHER:
Upadacitinib
Sponsor
Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse